Evaluation of outbreak response immunization in the control of pertussis using agent-based modeling

PeerJ

Volumn 2016, Issue 8, 2016, Pages

  Doroshenko, Alexander ^a   Qian, Weicheng ^b   Osgood, Nathaniel D ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Agent based modeling; Outbreak response immunization; Pertussis; Waning immunity

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; EMERGENCY MEDICINE; HUMAN; IMMUNIZATION; INCIDENCE; OUTBREAK RESPONSE IMMUNIZATION; PERTUSSIS; PUBLIC HEALTH; SENSITIVITY ANALYSIS; SIMULATION;

EID: 84992111607     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.2337     Document Type: Article

References (45)

1. Alberta Health. 2015. Interactive health data application. Available at http://www.ahw. gov.ab.ca/IHDA_Retrieval/(accessed on 26 December 2015).
2. California Department of Public Health. 2015. Pertussis report. Available at http://www. cdph.ca.gov/programs/immunize/Documents/PertussisReport2-12-2015.pdf (accessed on 26 December 2015).
3. Campbell PT, McCaw JM, McVernon J. 2015. Pertussis models to inform vaccine policy. Human Vaccines & Immunotherapeutics 11(3):669-678 DOI 10.1080/21645515.2015.1011575.
4. Centers for Disease Control and Prevention. 2013. Advisory Committee on Immu-nization Practices. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women. Morbidity and Mortality Weekly Report 62:131-135.
5. Centers for Disease Control and Prevention. 2015. Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and prevention of vaccine-preventable diseases. 13th edition. Washington, D.C.: Public Health Foundation.
6. Deeks SL, Lim GH, Walton R, Fediurek J, Lam F, Walker C, Walters J, Crowcroft NS. 2014. Prolonged pertussis outbreak in Ontario originating in an under-immunized religious community. Canada Communicable Disease Report Volume 40-3. Available at http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/14vol40/dr-rm40-03/dr-rm40-03-ont-eng.php (accessed on 26 December 2015).
7. Fabricius G, Bergero PE, Ormazabal ME, Maltz AL, Hozbor DF. 2013. Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina. Epidemiology and Infection 141(4):718-734 DOI 10.1017/S0950268812001380.
8. Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. 2015. A change in vaccine efficacy and duration of protection explains recent rises in per-tussis incidence in the United States. PLoS Computational Biology 11(4):e1004138 DOI 10.1371/journal.pcbi.1004138.
9. Grenfell RT, Anderson RM. 1989. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proceedings of the Royal Society London B Biological Sciences 236:213-252 DOI 10.1098/rspb.1989.0022.
10. Grimm V, Revilla E, Berger U, Jeltsch F, Mooij WM, Railsback SF, Thulke HH, Weiner J, Wiegand T, DeAngelis DL. 2005. Pattern-oriented modeling of agent-based complex systems: lessons from ecology. Science 310(5750):987-991.
11. Healy CM, Rench MA, Wootton SH, Castagnini LA. 2015. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. The Pediatric Infectious Disease Journal 34(1):22-26 DOI 10.1097/INF.0000000000000486.
12. Hethcote HW. 1997. An age-structured model for pertussis transmission. Mathematical Biosciences 145(2):89-136 DOI 10.1016/S0025-5564(97)00014-X.
13. Hethcote HW, Horby P, McIntyre P. 2004. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 22:2181-2191 DOI 10.1016/j.vaccine.2003.11.053.
14. Jackson DW, Rohani P. 2014. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiology and Infection 142(4):672-684 DOI 10.1017/S0950268812003093.
15. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. 2012. Waning protection after fifth dose of a cellular pertussis vaccine in children. New England Journal of Medicine 367(11):1012-1019 DOI 10.1056/NEJMoa1200850.
16. Libster R, Edwards KM. 2012. Re-emergence of pertussis: what are the solutions? Expert Review of Vaccines 11(11):1331-1346 DOI 10.1586/erv.12.118.
17. Mabry PL, Marcus SE, Clark PI, Lieschow SJ, Mendez D. 2010. Systems science: a revolution in public health policy research. American Journal of Public Health 100(7):1161-1163 DOI 10.2105/AJPH.2010.198176.
18. McGirr A, Fisman DN. 2015. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics 135(2):331-343 DOI 10.1542/peds.2014-1729.
19. Meade BD, Plotkin SA, Locht C. 2014. Possible options for new pertussis vaccines. Journal of Infectious Diseases 209(Suppl 1):S24-S27 DOI 10.1093/infdis/jit531.
20. Miguez Santiyan A, Ferrer Estrems R, Chover Lara JL, Alberola Enguidanos J, Nogueira Coito JM, Salazar Cifre A. 2015. Early intervention in pertussis outbreak with high attack rate in cohort of adolescents with complete acellular pertussis vaccination in Valencia, Spain, April to May 2015. Euro Surveillance 20(27) DOI 10.2807/1560-7917.ES2015.20.27.21183.
21. Minnesota Department of Health. 2012. Pertussis. Available at http://www.health.state. mn.us/divs/idepc/newsletters/dcn/sum12/pertussis.html (accessed on 26 December 2015).
22. Office of the Chief Medical Officer of Health. 2013. New Brunswick 2013 communi-cable disease annual report. Available at http://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/CDC/HealthProfessionals/Annual_Report_CDC_Branch_2013.pdf (accessed on 15 May 2016).
23. Office of the Chief Medical Officer of Health. 2014a. Pertussis outbreak investigation report. Available at http://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/CDC/HealthProfessionals/PertussisReport.pdf (accessed on 26 December 2015).
24. Office of the Chief Medical Officer of Health. 2014b. New Brunswick 2014 commu-nicable disease annual report. Available at http://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/CDC/HealthProfessionals/Annual_Report_CDC_Branch_2014.pdf (accessed on 15 May 2016).
25. Pesco P, Bergero P, Fabricius G, Hozbor D. 2013. Assessment of pertussis vaccination strategies using a mathematical model of disease transmission. Archivos Argentinos de Pediatr�a 111(5):377-383.
26. Pesco P, Bergero P, Fabricius G, Hozbor D. 2015. Mathematical modeling of delayed pertussis vaccination in infants. Vaccine 33(41):5475-5480 DOI 10.1016/j.vaccine.2015.07.005.
27. Public Health Agency of Canada. 2014a. Canadian immunization guide. Pertussis vaccine. Available at http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-pert-coqu-eng.php#a4 (accessed on 26 December 2015).
28. Public Health Agency of Canada. 2014b. National Advisory Committee on Immuniza-tion. An advisory statement. Update on pertussis vaccination in pregnancy. Available at http://www.phac-aspc.gc.ca/naci-ccni/acs-dcc/2014/pvip-vcpg_0214-eng.php (accessed on 26 December 2015).
29. Public Health Agency of Canada. 2015. Vaccine coverage amongst adult Canadians: results from the 2012 adult National Immunization Coverage (aNIC) survey. Available at http://www.phac-aspc.gc.ca/im/nics-enva/vcac-cvac-eng.php (accessed on 26 December 2015).
30. Public Health Ontario. 2014. Immunization coverage report for school pupils. Available at https://www.publichealthontario.ca/en/eRepository/Immunization_coverage_report_2012-13.pdf (accessed on 26 December 2015).
31. Railsback SF, Grimm V. 2012. Agent-based and individual-based modeling: a practical introduction. Princeton: Princeton University Press.
32. Rosenblum E, McBane S, Wang W, Sawyer M. 2014. Protecting newborns by immuniz-ing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic. Public Health Reports 129(3):245-251.
33. Sanstead E, Kenyon C, Rowley S, Enns E, Miller C, Ehresmann K, Kulasingam S. 2015. Understanding trends in pertussis incidence: an agent-based model approach. American Journal of Public Health 105(9):e42-e47.
34. Sheridan SL, Frith K, Snelling TL, Grimwood K, McIntyre PB, Lambert SB. 2014. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Review of Vaccines 13(9):1081-1106 DOI 10.1586/14760584.2014.944167.
35. Smith T, Rotondo J, Desai S, Deehan H. 2014. Pertussis surveillance in Canada: trends to 2012. Canada Communicable Disease Report. Available at http://www.phac-aspc.gc. ca/publicat/ccdr-rmtc/14vol40/dr-rm40-03/dr-rm40-03-per-eng.php (accessed on 26 December 2015).
36. Tan T, Dalby T, Forsyth K. 2015. Pertussis across the globe: recent epidemiologic trends from 2010 to 2013. The Pediatric Infectious Disease Journal 34(9):e222-e232.
37. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martins S, Messon-nier NE, Clark TA, Skoff TH. 2013. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 131(4):e1047-e1052 DOI 10.1542/peds.2012-1928.
38. Topping CJ, Hoye TT, Olesen CR. 2010. Opening the black box-development, testing and documentation of a mechanistically rich agent-based model. Ecological Modelling 221:245-255 DOI 10.1016/j.ecolmodel.2009.09.014.
39. Van Rie A, Hethcote HW. 2004. Adolescent and adult pertussis vaccination: computer simulation of five new strategies. Vaccine 22:3154-3165 DOI 10.1016/j.vaccine.2004.01.067.
40. Warfel JM, Zimmerman LI, Merkel TJ. 2014. Acellular pertussis vaccine protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proceedings of the National Academy of Sciences of the United States of America 111(2):787-792 DOI 10.1073/pnas.1314688110.
41. Wearing HJ, Rohani P. 2009. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathogens 5:e1000647 DOI 10.1371/journal.ppat.1000647.
42. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. 2005. Duration of immunity against pertussis after natural infection orvaccination. Pediatric Infectious Disease Journal 24(5 Suppl):S58-S61 DOI 10.1097/01.inf.0000160914.59160.41.
43. Wisconsin Department of Health Services. 2012. Annual pertussis surveillance sum-mary. Oregon reference adolescent peak. Available at https://www.dhs.wisconsin.gov/immunization/2012asrpertussis.pdf (accessed on 26 December 2015).
44. World Health Organization. 2009. Pertussis working group report. Available at www. who.int/immunization/sage/pertussis_SAGE_oct09.pdf (accessed on 26 December 2015).
45. World Health Organization. 2014. SAGE pertussis working group background paper. Available at http://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf (accessed on 26 December 2015).